http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1191858-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-02 |
| filingDate | 1982-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1985-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f3bb6a83b4b9972024fe0824814321f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09bb744ab799e56b71c1c9e71ba50174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3f1d3a0348805cb0555be615943199e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00e05d41d1942ae4e7dbd49d4ba9ddae |
| publicationDate | 1985-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1191858-A |
| titleOfInvention | Vitamin d.sub.3 derivatives and process for producing the same |
| abstract | Abstract of the Disclosure: There are disclosed 6,19-epidioxyvitamin D3 deriva-tives which are represented by the formula wherein Rl, R2 and R3 are each a hydrogen atom or a hydroxyl group; when Rl is a hydrogen atom, R2 represents a hydroxyl group and R3 is a hydrogen atom or a hydroxyl group; when both Rl and R2 represent a hydroxyl group, R3 is a hydrogen atom or a hydroxyl group; and when Rl is a hydroxyl group and R2 is a hydroqen atom, R3 represents a hydroxyl group. The compounds are highly capable of inducing differentiation of human myeloid leukemia cells with minimum effects on calcium metabolism and are useful as an agent to treat leukemia. |
| priorityDate | 1981-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.